115 related articles for article (PubMed ID: 9592252)
1. [Experimental study of adoptive immunotherapy for adenoid cystic carcinoma of the salivary gland].
Li X; Zhou Z; Peng Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Sep; 31(5):271-3. PubMed ID: 9592252
[TBL] [Abstract][Full Text] [Related]
2. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
Wang Z; Cheng Y; Zheng R; Qin D; Liu G
Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
Reiter Z; Taylor MW
Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of radiation combined with tumor draining lymphocytes on human ACC-M cell in vitro].
Cai Y; Qiu W; He R
Zhonghua Kou Qiang Yi Xue Za Zhi; 2000 Jul; 35(4):245-7. PubMed ID: 11780497
[TBL] [Abstract][Full Text] [Related]
5. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
Wu R; Coleman N; Stanley M
Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
[TBL] [Abstract][Full Text] [Related]
6. Cytolysis of malignant glioma cells by lymphokine-activated killer cells combined with anti-CD3/antiglioma bifunctional antibody and tumor necrosis factor-alpha.
Yoshida J; Takaoka T; Mizuno M; Momota H; Okada H
J Surg Oncol; 1996 Jul; 62(3):177-82. PubMed ID: 8667624
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers.
Nio Y; Zighelboim J; Berek JS; Bonavida B
Anticancer Res; 1990; 10(2A):441-6. PubMed ID: 2346317
[TBL] [Abstract][Full Text] [Related]
8. Tretinoin or retinol enhancement of lymphokine-activated killer cell proliferation and cytotoxicity against human bladder cancer cells in vitro.
Wang ZP; Zheng RL; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):522-4. PubMed ID: 10322910
[TBL] [Abstract][Full Text] [Related]
9. [The study of apoptosis of salivary adenoid cystic carcinoma in nude mice].
Wang J; Dong FS; Dong Q; Gu HT; Li HX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Sep; 38(5):358-60. PubMed ID: 14680585
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor.
Teichmann JV; Ludwig WD; Thiel E
Leuk Res; 1992; 16(3):287-98. PubMed ID: 1560676
[TBL] [Abstract][Full Text] [Related]
11. [The effects of IFN-gamma on the antitumor abilities of immunocytes and chemotherapeutic agents].
Gu Q; Zhu Z; Yin H
Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):89-91. PubMed ID: 10374484
[TBL] [Abstract][Full Text] [Related]
12. [Differentiation therapy for salivary gland tumors].
Sato M
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1028-36. PubMed ID: 7685583
[TBL] [Abstract][Full Text] [Related]
13. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
14. [The effect of interleukin-2, interleukin-4 and tumor necrosis factor on LAK cells activity].
Zeng Z; Si CW; Yu M
Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):235-7, 256. PubMed ID: 7922766
[TBL] [Abstract][Full Text] [Related]
15. Effects of interferon-alpha and gamma on development of LAK activity from mononuclear cells in breast cancer patients.
Kamamura Y; Takahashi K; Komaki K; Monden Y
J Med Invest; 1998 Aug; 45(1-4):71-5. PubMed ID: 9864966
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for adenoid cystic carcinoma of salivary glands: cancer/testis antigens and 5-aza-2'-deoxycytidine.
Liang S; Fan M
Med Hypotheses; 2009 Nov; 73(5):768-9. PubMed ID: 19481355
[TBL] [Abstract][Full Text] [Related]
17. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
Falk CS; Noessner E; Weiss EH; Schendel DJ
Cancer Res; 2002 Jan; 62(2):480-7. PubMed ID: 11809699
[TBL] [Abstract][Full Text] [Related]
18. [Observations of cellular differentiation behaviour in adenoid cystic carcinoma of human salivary gland in vitro].
He R; Zhou X; Xia W
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 May; 31(3):150-2. PubMed ID: 9387555
[TBL] [Abstract][Full Text] [Related]
19. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
20. [Cytotoxicity of human lymphokine-activated killer cells against mitotic phase tumor cells].
Liu GR
Zhonghua Yi Xue Za Zhi; 1993 Sep; 73(9):547-8, 576. PubMed ID: 8313200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
